Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
The use ofFrontiers in cell and developmental biology · 2026
Review
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors.
Travis J PhilyawBioscience Graduate Program, University of Utah, Salt Lake City, Utah 84112.
Iris TitosDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah Health, Salt Lake City, Utah 84108.
Pearl N Cummins-BeebeeNeuroscience Graduate Program, University of Utah, Salt Lake City, Utah 84112.
Aylin R RodanMolecular Medicine Program, University of Utah Health, Salt Lake City, Utah 84112.ORCID 0000-0001-9202-2378
Adrian RothenfluhDepartment of Neurobiology, University of Utah Health, Salt Lake City, Utah 84112 Adrian.Rothenfluh@hsc.utah.edu.ORCID 0000-0002-3813-5723
Funding
Control of Alcohol Responses by Actin-Regulating GenesR01AA019526 · NIAAA · UT SOUTHWESTERN MEDICAL CENTER · PI ROTHENFLUH, ADRIAN · 2010 to 2025
$5.4M
Regulation of WNK signaling by potassium and Mo25: structure, function and physiologyR01DK110358 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RODAN, AYLIN RACHEL · 2016 to 2025
$4.1M
Transcriptional Regulation of Alcohol Sensitivity and ToleranceR01AA030881 · NIAAA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Adrian Rothenfluh · 2023 to 2026
$2.1M
Mechanisms of alcohol-induced plasticitey mediated by Arf6R01AA026818 · NIAAA · UNIVERSITY OF UTAH · PI ROTHENFLUH, ADRIAN · 2018 to 2022
$1.7M
Mechanisms of diet modulating experience-dependent amphetamine preferenceK01DA058919 · NIDA · UNIVERSITY OF UTAH · PI Iris Titos Vivancos · 2024 to 2026
$571k
ATAC-ing dopaminergic cell identity with single-cell resolutionR21DA049635 · NIDA · UNIVERSITY OF UTAH · PI ROTHENFLUH, ADRIAN · 2019 to 2020
$419k
Engineering Drosophila that self-administer cocaineR21DA040439 · NIDA · UNIVERSITY OF UTAH · PI ROTHENFLUH, ADRIAN · 2016 to 2017
$405k
Genetics of Amphetamine PreferenceR21DA060453 · NIDA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI ROTHENFLUH, ADRIAN · 2024 to 2025
Cocaine is an addictive psychostimulant, and the risk of developing cocaine use disorder (CUD) is highly heritable. Little is known about the specific genes and mechanisms that lead to the development of CUD, and there are currently no FDA-approved pharmacotherapies that can treat it.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Bitter Sensing Protects · full record | OpenQuestion